BELCARO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.693
EU - Europa 4.573
AS - Asia 1.880
SA - Sud America 19
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 5
Totale 11.200
Nazione #
US - Stati Uniti d'America 4.660
CN - Cina 992
UA - Ucraina 941
IE - Irlanda 923
TR - Turchia 650
IT - Italia 605
SE - Svezia 584
GB - Regno Unito 430
FR - Francia 342
DE - Germania 317
FI - Finlandia 189
IN - India 123
PL - Polonia 76
BE - Belgio 32
RU - Federazione Russa 30
CA - Canada 21
ES - Italia 21
KR - Corea 18
TH - Thailandia 17
AT - Austria 15
HK - Hong Kong 14
BR - Brasile 13
EU - Europa 13
IR - Iran 13
NL - Olanda 13
AU - Australia 12
ID - Indonesia 11
JP - Giappone 9
VN - Vietnam 9
GR - Grecia 8
MX - Messico 8
CH - Svizzera 7
PT - Portogallo 7
TW - Taiwan 7
CZ - Repubblica Ceca 6
RO - Romania 6
AR - Argentina 5
DK - Danimarca 5
NZ - Nuova Zelanda 5
HR - Croazia 4
IL - Israele 4
PH - Filippine 4
SG - Singapore 4
SK - Slovacchia (Repubblica Slovacca) 4
LU - Lussemburgo 2
MA - Marocco 2
NI - Nicaragua 2
PK - Pakistan 2
AL - Albania 1
BG - Bulgaria 1
CR - Costa Rica 1
EG - Egitto 1
GT - Guatemala 1
JO - Giordania 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
ME - Montenegro 1
MY - Malesia 1
PE - Perù 1
SC - Seychelles 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 11.200
Città #
Jacksonville 1.210
Dublin 916
Chandler 912
Princeton 448
Izmir 368
Nanjing 360
Southend 354
Wilmington 194
Cambridge 193
Altamura 188
Ashburn 133
Ann Arbor 131
Nanchang 120
Dearborn 110
Beijing 103
Boardman 71
Kraków 65
Shenyang 65
Hebei 58
Kunming 50
Tianjin 50
Woodbridge 44
Jiaxing 43
New York 32
Norwalk 32
Brussels 26
Changsha 24
Chieti 23
Los Angeles 22
Falls Church 21
Washington 21
Grevenbroich 18
Rome 18
Hangzhou 17
Houston 15
Lanzhou 15
San Mateo 15
Jinan 14
Foggia 13
Changchun 12
Ningbo 12
Hanover 11
Seattle 11
Auburn Hills 10
Milan 10
Shanghai 10
Augusta 9
Bangkok 9
Guangzhou 9
Vienna 9
Collecorvino 8
Guardiagrele 8
Helsinki 8
Istanbul 8
Leawood 8
Orange 8
Redwood City 8
Toronto 8
Hong Kong 7
Kuopio 7
London 7
Zhengzhou 7
Dong Ket 6
Madrid 6
Mcallen 6
Mountain View 6
Warsaw 6
Atlanta 5
Dallas 5
Garbagnate Milanese 5
Hefei 5
Moscow 5
Mérignac 5
Taipei 5
Ardabil 4
Bari 4
Bratislava 4
Cormeilles-en-Parisis 4
Mexico 4
Minneapolis 4
Montréal 4
Orsogna 4
Selcuklu 4
Seoul 4
Siena 4
Sydney 4
Taizhou 4
Zurich 4
Ahmedabad 3
Barcelona 3
Bergamo 3
Brno 3
Catania 3
Catanzaro 3
Chivasso 3
Cinisello Balsamo 3
Dortmund 3
Edinburgh 3
Forlì 3
Grafing 3
Totale 6.873
Nome #
Beanblock® (standardized dry extract of Phaseolus vulgaris) in mildly overweight subjects: a pilot study. 120
Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids. 114
Venoruton vs Daflon: evaluation of effects on qualità of life chronic venous insuffciency 114
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 104
Postoperative pulmonary infections: role of antibiotic treatment 103
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 103
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 100
Robuvit® and endurance in triathlon: improvements in training performance, recovery and oxidative stress 97
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 97
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 94
Jet-lag: prevention with Pycnogenol. Preliminary report: evaluation in healthy individuals and in hypertensive patients 92
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 89
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 88
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 84
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 84
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 84
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 82
Treatment of ankle sprain in patients with vascular diseases of the lower limbs 81
Mononucleosis-related fatigue: supplementary management with Robuvit®. 81
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 80
Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. 79
Topical heparin: New observations 78
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 78
Incidence of perioperative stroke during peripheral revascularization or aortocoronary bypass in patients with carotid bruit and stenosis 76
Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins 75
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 74
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 74
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 73
Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol 73
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. 73
The value of segmental pressure measurement in the assessment of peripheral vascular disease. 72
[Comparison of netilmicin with other aminoglycosides in severe surgical infections]. 71
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 70
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 70
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. 69
Treatment of Osteoarthritis with Pycnogenol®. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of Signs, Symptoms,Physical Performance and Vascular Aspects 69
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 68
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 68
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 68
O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study 67
null 67
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 67
THE VENOUS CLINIC 67
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 67
Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study 67
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 66
[Breast cancer. Epidemiology and other factors related to incidence in various populations]. 66
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 66
Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. 65
Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary report. 65
Microcirculatory effects of Viatromb® spray gel heparin in chronic venous insufficiency: Evaluation of TcPO2 and PCO2 - A product evaluation study 65
Robuvit®: improvement of fatigue in medical convalescence. 65
Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. 64
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 64
Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®). 64
Laser doppler flux in the venous wall 63
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. 63
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 63
5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-(β-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry 63
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 62
LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathy 62
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 62
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 61
Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography. 61
Cramps and Muscular Pain: Prevention with Pycnogenol((R)) in Normal Subjects, Venous Patients, Athletes, Claudicants and in Diabetic Microangiopathy 61
Trombosi venose ed embolie 61
Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study 61
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 60
Methods of Evaluation and Quantification of Microangiopathy in High Perfusion Microangiopathy (Chronic Venous Insufficiency and Diabetic Microangiopathy) 60
Circulating endothelail cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton 60
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 60
Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment. 60
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 60
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 60
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 59
Trombosi venosa ed embolia polmonare 59
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 59
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 59
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit® 59
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 59
Pycnogenol may alleviate adverse effects in oncologic treatment 58
Superficial vein thrombosis (SVT), diffusion of thrombotic diseases, and increased global thrombogenicity: SVT as an important spy disease indicating environmental contamination by estrogens - Introduction 58
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 58
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 57
Computerized ultrasonic angiography. Current applications and comparison with other noninvasive and invasive methods 57
Improvement in cochlear flow in patients with tinnitus with the complex supplement Acustop: a product evaluation 56
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 56
Local heparin, superficial vein thrombosis 56
Treatment of intermittent claudication with pentoxifylline: A 12-month, randomized trial: Walking distance and microcirculation 56
Improvement of microcirculation and healing of venous hypertension and ulcers with Crystacide: evaluation with a microcirculatory model, including free radicals, laser doppler flux, and PO2/PCO2 measurements. 55
HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. 55
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 55
Kidney flow and function in hypertension: protective effects of pycnogenol in hypertensive participants--a controlled study. 55
Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases 54
Rapid relief of signs/symptoms in chronic venous micronagiopathy with Pycnogenol: a prospective, controlled study. 54
Valutazione dei fattori di rischio per lo stroke in pazienti con insufficienza cerebrovascolare 54
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 54
Prevention of edema in long flights with Pycnogenol 53
Laser-Doppler flowmetry evaluation of the effects of elastic compression in patients with venous ulcerations. 53
Lady Prelox® improves sexual function in generally healthy women of reproductive age. 53
Totale 6.945
Categoria #
all - tutte 39.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019508 0 0 0 0 0 0 0 0 0 0 23 485
2019/20202.460 835 198 53 70 208 95 247 231 65 144 278 36
2020/20211.130 224 21 238 30 87 267 20 9 84 92 23 35
2021/2022889 16 18 17 170 80 25 19 66 68 17 105 288
2022/20232.766 277 414 158 285 237 582 185 179 279 27 88 55
2023/20241.050 89 51 65 29 52 292 345 38 24 61 4 0
Totale 11.681